Evidence map›Paper›PMID 31173234›Full record

ArticleMolecular medicine reports2019

Downregulation of microRNA‑451 improves cell migration, invasion and tube formation in hypoxia‑treated HUVECs by targeting MIF.

Qian Li, Yongqiu Li, Dongsen Zhang, Haifeng Gao, Xuan Gao

Open access · hybridAbstract read
In one paragraph

Article in Molecular medicine reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. MiRNA Dysregulation in Brain Injury: AnCurrent neuropharmacology · 2025
    Article
  6. Review
  7. Article
  8. Review
  9. Dualistic roles and mechanistic insights of macrophage migration inhibitory factor in brain injury and neurodegenerative diseases.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2023
    Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Qian LiDepartment of Neurology, The Workers' Hospital of Tangshan City, Tangshan, Hebei 063000, P.R. China.
Yongqiu LiDepartment of Neurology, The Workers' Hospital of Tangshan City, Tangshan, Hebei 063000, P.R. China.
Dongsen ZhangDepartment of Neurology, The Workers' Hospital of Tangshan City, Tangshan, Hebei 063000, P.R. China.
Haifeng GaoDepartment of Neurology, The Workers' Hospital of Tangshan City, Tangshan, Hebei 063000, P.R. China.
Xuan GaoDepartment of Neurology, The Workers' Hospital of Tangshan City, Tangshan, Hebei 063000, P.R. China.
Liaoning Provincial People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Angiogenesis is a critical process of recovery from cerebrovascular disease. A growing body of evidence has confirmed that microRNAs (miRNAs/miRs) have an important role in the modulation of angiogenesis under physiological and pathological conditions including cerebral ischemia injury (CII). Therefore, the aim of the present study was to explore the function and mechanism of microRNAs in regulating angiogenesis using a cell model of CII. Firstly, a miRNA microarray was performed to analyze miRNA expression in serum samples from patients with cerebral ischemia and the results revealed that miR‑451 was one of the miRNAs that was the most significantly downregulated. Subsequently, human umbilical vein endothelial cells (HUVECs) were used as an in vitro model to further explore the mechanisms governing angiogenesis during hypoxia. The results demonstrated that overexpression of miR‑451 had a significantly anti‑angiogenic effect by suppressing tube formation, migration and wound healing in vitro. By contrast, reducing the expression of miR‑451 promoted HUVEC migration and tubulogenesis under normoxic conditions. The present study further identified that macrophage migration inhibitory factor (MIF), an important angiogenic regulator, was a novel target of miR‑451 that could reverse the effects of miR‑451 on the regulation of angiogenesis in HUVECs under hypoxic or normoxic conditions. These results revealed that downregulation of miR‑451 promotes angiogenesis by targeting MIF in hypoxic HUVECs and indicated that miR‑451 is a potential candidate for CII therapeutics.

Indexed as

Cell MovementAgedBrain IschemiaFemaleGene Expression RegulationHumansHuman Umbilical Vein Endothelial CellsHypoxiaIntramolecular OxidoreductasesMacrophage Migration-Inhibitory FactorsMaleMicroRNAsMiddle AgedNeovascularization, PathologicNeovascularization, PhysiologicIntramolecular OxidoreductasesMacrophage Migration-Inhibitory FactorsMicroRNAsMIF protein, humanMIRN451 microRNA, human

Identifiers

PMID31173234
PMCPMC6625462
OpenAlexW2954264754

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.